Page 47 - GTM-2-2
P. 47

Global Translational Medicine                                                    FTO gene and obesity




                         70
                         60
                         50
                         40
                         30
                         20
                         10
                          0
                              rs10852521  rs11075990  rs1121980  rs1421085  rs1477196  rs17817449  rs3751812  rs4783819  rs7206790  rs8047395  rs9939609  rs9940128  rs9941349




                                             Global  Afr  Amr  Eas  Eur  Belarus
            Figure 1. Minor allele frequency in populations.

            Table 1. Candidate polymorphic variants included in the study  program were approved by the Bioethics Committee of the
                                                               Belarusian Medical Academy of Postgraduate Education.
            SNP          SNP Location   SNP Type  MAF Global
            rs10852521 C/T  Chr. 16:53771053  Intron 1  0.40 (T)  2 ML of peripheral venous blood samples was collected
            rs11075990 A/G  Chr. 16:53785981  Intron 1  0.34 (G)  into EDTA tubes. Genomic DNA extraction was carried
                                                               out by the Eppendorf epMotion 5075 multifunctional
            rs1121980 C/T  Chr. 16:53775335  Intron 1  0.37 (T)  automatic station using Art NK Magnit kits (ArtBioTech
            rs1421085 C/T  Chr. 16:53767042  Intron 1  0.23 (C)  LLC, the Republic of Belarus) for nucleic acid extraction
            rs1477196 A/G  Chr. 16:53774346  Intron 1  0.27 (A)  on magnetic particles in accordance with manufacturer’s
            rs17817449 G/T  Chr. 16:53779455  Intron 1  0.31 (G)  instructions. The DNA quantity was measured using
            rs3751812 G/T  Chr. 16:53784548  Intron 1  0.22 (T)  the GloMax Explorer (Promega, USA), a multimode
            rs4783819 G/C  Chr16:53782735  Intron 1  0.30 (G)  microplate reader, and the extracted DNA was stored at
            rs7206790 G/C  Chr16:53763996  Intron 1  0.40 (G)  −20°C until use.
            rs8047395 A/G  Chr16:53764611  Intron 1  0.41 (G)  2.2. Clinical examination
            rs9939609 T/A  Chr16:53786615  Intron 1  0.34 (A)  Clinical examination and the collection of blood samples
            rs9940128 A/G  Chr16:53766842  Intron 1  0.36 (A)  were performed at the clinical bases of the Department
            rs9941349 C/T  Chr16:53791576  Intron 1  0.27 (T)  of Endocrinology of the Belarusian Medical Academy of
            MAF: Minor allele frequency; SNP: Single nucleotide polymorphism  Postgraduate Education. Clinical examination included
                                                               an assessment of anthropometric characteristics and an
            2. Materials and methods                           endocrinologist checkup to exclude patients with severe
                                                               somatic conditions, concomitant chronic diseases at the
            2.1. Study participants
                                                               decompensation stage, pregnancy or lactation periods,
            The study involved 655 volunteers over the age of 18 years   severe  infectious  processes  (HIV  infection,  tuberculosis,
            living in the territory of the Republic of Belarus. Among   syphilis, and a progressive course of viral hepatitis B and C).
            them, the control group included 273 volunteers with BMI   Anthropometric measurements were performed in
            < 25, 170 obese patients with BMI > 30, and 212 individuals   accordance with the WHO and International Diabetes
            in the pre-obesity state. The minimum sample size was   Federation requirements. Height was measured with an
            estimated in the study using the two-group proportion   accuracy of 0.1 cm and body weight was measured with
            formula with  α at 0.05, power of 80%, p1  =  0.40 and   an accuracy of 0.1 kg using TANITA floor bioimpedance
            p2 = 0.56. The final minimum sample size was 150 cases   scales (a body composition analyzer; TF-780, Japan) to
            per group. The study participants gave informed consent to   analyze the percentage of adipose tissue distribution.
            participate in the study in accordance with the Declaration   Body mass index was calculated using the following
            of Helsinki (as amended in 2013) and were invited to   formula: BMI = Body weight (kg)/height (m) . The study
                                                                                                    2
            the  survey.  The  informed  consent  form  and  the  study   participants  were  categorized  into  groups  based  on  the

            Volume 2 Issue 2 (2023)                         3                         https://doi.org/10.36922/gtm.352
   42   43   44   45   46   47   48   49   50   51   52